Correvio Pharma Corp. Gains 61.12%
Mon, Feb 24, 2020 at 05:30 PM
Correvio Pharma Corp. (CORV:NASDAQ) shot up at $0.47, a gain of 61.1%. On Fri 21 Feb 20, CORV:NASDAQ hit a New 2-Week Intraday Low of $0.27. The stock appeared on our News Catalysts scanner on Mon 10 Feb 20 at 03:38 PM in the 'INVESTOR UPDATE' category. From Fri 31 Jan 20, the stock recorded 21.43% Up Days and 26.67% Green Days
The share price of the company has been moving sideways in recent weeks.
About Correvio Pharma Corp. (CORV:NASDAQ)
Cardiome Pharma Corp is a specialty pharmaceutical company. It is engaged in the development and commercialization of cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease.
Top 10 Gainers:
- Lipocine Inc. (LPCN:NASDAQ), 67.39%
- Correvio Pharma Corp. (CORV:NASDAQ), 61.12%
- NanoViricides, Inc. (NNVC:NYSEMKT), 38.37%
- VelocityShares Daily 2x VIX Short-Term ETN (TVIX:NASDAQ), 37.05%
- Ambow Education Holding Ltd. (AMBO:NYSEMKT), 34.91%
- Endologix, Inc. (ELGX:NASDAQ), 34.35%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 28.85%
- NYSE Tick Pilot Test Sym-Contro (NTEST:NYSE), 27.92%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 27.24%
- Document Security Systems, Inc. (DSS:NYSEMKT), 26.33%